KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Accounts Payables: 2009-2025

Historic Accounts Payables for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $616.0 million.

  • Bausch Health Companies' Accounts Payables fell 7.65% to $616.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $616.0 million, marking a year-over-year decrease of 7.65%. This contributed to the annual value of $589.0 million for FY2024, which is 18.08% down from last year.
  • Latest data reveals that Bausch Health Companies reported Accounts Payables of $616.0 million as of Q3 2025, which was down 1.75% from $627.0 million recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Accounts Payables registered a high of $719.0 million during Q4 2023, and its lowest value of $342.0 million during Q1 2021.
  • Moreover, its 3-year median value for Accounts Payables was $616.0 million (2025), whereas its average is $609.5 million.
  • In the last 5 years, Bausch Health Companies' Accounts Payables fell by 22.97% in 2021 and then skyrocketed by 38.00% in 2023.
  • Bausch Health Companies' Accounts Payables (Quarterly) stood at $407.0 million in 2021, then climbed by 28.01% to $521.0 million in 2022, then surged by 38.00% to $719.0 million in 2023, then decreased by 18.08% to $589.0 million in 2024, then decreased by 7.65% to $616.0 million in 2025.
  • Its last three reported values are $616.0 million in Q3 2025, $627.0 million for Q2 2025, and $620.0 million during Q1 2025.